BREAKING: China Confirms Song Li’s WHO Leadership Bid, Reshuffling Race Amidst Fraught Multilateral Landscape
Chinese Foreign Ministry spokesperson Mao Ning briefing reporters in Beijing, where she confirmed Song Li’s nomination and reiterated China’s commitment to multilateralism.
Chinese Foreign Ministry spokesperson Mao Ning briefing reporters in Beijing, where she confirmed Song Li’s nomination and reiterated China’s commitment to multilateralism.

Beijing confirmed the nomination of National Health Commission official Dr Song Li for WHO Director-General on Thursday (8 October). The move expands the candidate field to seven amidst severe geopolitical ruptures shaking up the agency, with experts warning this move could further heighten superpower tensions.

In announcing the bid, Chinese officials framed the candidacy around global solidarity and strengthening multilateralism.

“China’s decision to nominate Dr Song Li reflects China’s aspiration to work for a global community of health for all and demonstrates China’s firm support for multilateralism,” Foreign Ministry spokesperson Mao Ning told reporters during a press briefing in response to a question by Reuters.

Song was nominated by the People’s Republic of China as WHO DG candidate.

“If elected, it will help the WHO play a more positive role in promoting the health and wellbeing of all humanity,” she added.

Song currently serves as Director-General of the Department of Women and Child Health in China’s National Health Commission. She is a physician-scientist trained at Peking University and Harvard, bringing over two decades of experience in maternal policy, epidemic response, and WHO technical advisory groups.

Observers note Song’s technical focus contrasts with established ministerial and diplomatic figures in the race.

Song Li bid spotlights China’s financial weight

China ranks fourth in overall WHO funding for 2025-2026 at $320 million, driven overwhelmingly by mandatory assessed dues rather than voluntary contributions.
China ranks fourth in overall WHO funding for 2025-2026 at $320 million, driven overwhelmingly by mandatory assessed dues rather than voluntary contributions.

Song’s nomination by the People’s Republic of China comes as WHO manages massive budget cuts following the withdrawal of the United States. Owing $280.9 million in unpaid arrears, Washington faces the suspension of its voting rights at the World Health Assembly.

Global health policy experts observe that Beijing aims to fill the leadership void left by Washington’s withdrawal. According to official numbers on the WHO website, China’s total financial contribution to the WHO for the 2025-2026 biennium stands at $320 million through August, making it the largest state contributor in terms of assessed funding after the US withdrawal.

Among state donors, China’s funding is exceptionally concentrated in mandatory assessed dues, contrasting with traditional Western state contributors, which distribute significant portions of their funding across core voluntary, thematic, and specified voluntary channels.

When compared against other major contributors, China ranks as the fourth-largest overall donor to the WHO, trailing only the Bill and Melinda Gates Foundation, the European Commission, and the World Bank, while sitting ahead of the United Kingdom, the GAVI Alliance, and Germany. While European Union Member States hold 27 votes in the WHA, the EU is not likely to vote en bloc, and two European nominees in the race could split their support.

Health Policy Watch reached out to the WHO asking to confirm the nomination and whether China had paid its dues for 2026 in full, but did not receive a response ahead of publication.

High geopolitical stakes for WHO

Lawrence Gostin doesn't see a global appetite for a Chinese DG candidate.
Lawrence Gostin doesn’t see a global appetite for a Chinese DG candidate.

Global health experts voiced serious doubts that a Chinese candidacy will indeed shake up the final race because of the high geopolitical stakes for the WHO.

“In the aftermath of COVID-19, I do not think there is a global appetite for a Chinese candidate for WHO Director-General,” Lawrence Gostin, professor of global health law at Georgetown University, told Health Policy Watch.

“A Chinese candidate would heighten geopolitical tensions, putting the WHO in a difficult and vulnerable position,” Gostin added. “It would also make rejoining the WHO far more difficult for the US, even under a Democratic administration.”

The friction stems from increased geopolitical competition between the two superpowers and a lingering political fallout over COVID-19 transparency and initial outbreak reporting. Gostin noted that bipartisan opposition in Washington and a lack of civil society support create formidable hurdles for Song across both North America and Europe.

European reactions remain divided. While one senior European official warned that a successful Chinese bid would test the WHO’s fundamental legitimacy and independence, others expressed less alarm, noting that Beijing’s diplomacy remains “very nuanced” and that China is viewed in Europe as a partner as well as a competitor.

Besides geopolitical scrutiny, China’s candidacy also faces structural UN hurdles regarding geographic distribution. With Dr Margaret Chan, a Hong Kong and Canadian national nominated by China, having served two terms as Director-General from 2006 to 2017 and a Chinese national heading the Food and Agriculture Organization, member states may resist concentrating UN agency leadership.

BREAKING: China Has Nominated Candidate for WHO Director General Whose Name Remains Undisclosed

Image Credits: Ministry of Foreign Affairs People’s Republic of China, WHO, WHO/HPW.

Combat the infodemic in health information and support health policy reporting from the global South. Our growing network of journalists in Africa, Asia, Geneva and New York connect the dots between regional realities and the big global debates, with evidence-based, open access news and analysis. To make a personal or organisational contribution click here on PayPal.